Novel GABRG2 mutations cause familial febrile seizures
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 25, 2015
- Accepted in final form September 30, 2015
- First Published November 4, 2015.
Author Disclosures
- Morgane Boillot,
- Mélanie Morin-Brureau, PhD,
- Fabienne Picard, MD, PhD,
- Sarah Weckhuysen, MD, PhD,
- Virginie Lambrecq, MD, PhD,
- Carlo Minetti, MD, PhD,
- Pasquale Striano, MD, PhD,
- Federico Zara, PhD,
- Michele Iacomino, PhD,
- Saeko Ishida, PhD,
- Isabelle An-Gourfinkel, MD, PhD,
- Mailys Daniau,
- Katia Hardies, PhD,
- Michel Baulac, MD,
- Olivier Dulac, MD,
- Eric Leguern, MD, PhD,
- Rima Nabbout, MD, PhD and
- Stéphanie Baulac, PhD
- Morgane Boillot,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Ligue Fran?aise contre l'Epilepsie
NONE
NONE
NONE
NONE
NONE
NONE
- Mélanie Morin-Brureau, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Fabienne Picard, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
a grant from the Swiss National Foundation No. 320030-127608
NONE
NONE
NONE
NONE
NONE
NONE
- Sarah Weckhuysen, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
French program ?Investissements d?avenir? (ANR-10-IAIHU-06)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Virginie Lambrecq, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) French program
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Carlo Minetti, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pasquale Striano, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Federico Zara, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michele Iacomino, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Saeko Ishida, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Japan Society for Promotion of Science (JSPS)
NONE
NONE
NONE
NONE
NONE
NONE
- Isabelle An-Gourfinkel, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mailys Daniau,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Katia Hardies, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Katia Hardies was a PhD fellow of the Institute for Science and Technology (IWT)-Flanders.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michel Baulac, MD,
UCB Eisai GSK SAGE GW Pharma
NONE
Received travel expenses and/or honoraria for lectures or educational activities funded by industry UCB, Received travel expenses and/or honoraria for lectures or educational activities funded by industry UCB, Eisai GSK isai GSK
NONE
NONE
NONE
NONE
UCB: review of study protocols Eisai: review of study protocols GSK: review of study protocols
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Olivier Dulac, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eric Leguern, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Program ?Investissements d?avenir? ANR-10-IAIHU-0 (2) INSERM (3) Assistance Publique des H?pitaux de Paris
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rima Nabbout, MD, PhD and
Novartis
NONE
Funding for travel from Shire Speaker honoraria from Novartis, cyberonics, Eisai
editorial advisory board member of Epilepsia
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stéphanie Baulac, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Program ?Investissements d?avenir? ANR-10-IAIHU-06,(2) Carnot Institute [N? CT010]
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From Sorbonne Universités (M.B., S.I., M.D., S.B., M.M.-B., E.L., S.W., M.B., V.L., I.A.-G.), UPMC Univ Paris 06, UM 75, ICM; INSERM, U1127 (M.B., S.I., M.D., S.B., M.M.-B., E.L., S.W., M.B., V.L., I.A.-G.), ICM; CNRS (M.B., S.I., M.D., S.B., M.M.-B., E.L., S.W., M.B., V.L., I.A.-G.), UMR 7225, ICM; ICM (M.B., S.I., M.D., S.B., M.M.-B., E.L., S.W., M.B., V.L., I.A.-G.), Paris, France; Department of Neurology (F.P.), University Hospitals of Geneva (HUG), Switzerland; Centre de Reference Épilepsies Rares, Epilepsy Unit (S.W., M.B., V.L., I.A.-G.), and Département de Génétique et de Cytogénétique (E.L.), AP-HP Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova (C.M., P.S.), and Laboratory of Neurogenetics, Department of Neurosciences (F.Z., M.I.), “G. Gaslini” Institute, Genova, Italy; Neurogenetics Group, VIB-Department of Molecular Genetics (K.H.), and Laboratory of Neurogenetics, Institute Born-Bunge (K.H.), University of Antwerp, Belgium; Centre de Reference Épilepsies Rares (O.D., R.N.), Department of Pediatric Neurology, Necker Enfants Malades Hospital, AP-HP, Paris; INSERM (O.D., R.N.), U1129, Necker, Paris, France; and University Paris Descartes (O.D., R.N.), Paris, France.
- Correspondence to Dr. Baulac: stephanie.baulac{at}upmc.fr
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.